Fibrinolytic abnormalities in acute respiratory distress syndrome (ARDS) and versatility of thrombolytic drugs to treat COVID‐19

View/Open
Whyte_etal_jth_Fibrinolytic_abnormalities_VOR.pdf (802.0Kb)
Publication date
07/2020
Author
Metadata
Show full item record
Citation
Whyte , C S , Morrow , G B , Mitchell , J L , Chowdary , P & Mutch , N J 2020 , ' Fibrinolytic abnormalities in acute respiratory distress syndrome (ARDS) and versatility of thrombolytic drugs to treat COVID‐19 ' , Journal of Thrombosis and Haemostasis , vol. 18 , no. 7 , pp. 1548-1555 . https://doi.org/10.1111/jth.14872
URI
https://hdl.handle.net/2164/14655
DOI
https://doi.org/10.1111/jth.14872
Rights
© 2020 The Authors. Journal of Thrombosis and Haemostasis published by Wiley Periodicals LLC on behalf of International Society on Thrombosis and Haemostasis. This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. https://creativecommons.org/licenses/by/4.0/
Collections